{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:50:54Z","timestamp":1790869854099,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005347","name":"American Association for the Study of Liver Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.aohep.2025.101935","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T19:34:09Z","timestamp":1750448049000},"page":"101935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["\u201cHepatocellular carcinoma surveillance: Current challenges in Latin America\u201d"],"prefix":"10.1016","volume":"30","author":[{"given":"Josefina","family":"Pages","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Mendizabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciela","family":"Castro-Narro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Mar\u00eda","family":"Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Gomes","family":"Da Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Poniachik","family":"Teller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"Girala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Fabricio Alarcon","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pi\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2025.101935_bib0001","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.aohep.2025.101935_bib0002","first-page":"226","article-title":"International Liver Cancer Association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance","volume":"79","author":"Singal","year":"2023"},{"key":"10.1016\/j.aohep.2025.101935_bib0003","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.3748\/wjg.v24.i37.4224","article-title":"Hepatocellular carcinoma in Latin America: diagnosis and treatment challenges","volume":"24","author":"Pi\u00f1ero","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2025.101935_bib0004","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.suc.2015.05.009","article-title":"Principles of cancer screening","volume":"95","author":"Pinsky","year":"2015","journal-title":"Surg Clin N Am"},{"key":"10.1016\/j.aohep.2025.101935_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100344","article-title":"Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice","volume":"25","author":"Dirchwolf","year":"2021","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2025.101935_bib0006","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s12029-020-00508-7","article-title":"Epidemiological and clinical patterns of newly diagnosed hepatocellular carcinoma in Brazil: the need for liver disease screening programs based on real-world data","volume":"52","author":"Fernandes G dos","year":"2021","journal-title":"J Gastrointest Cancer"},{"key":"10.1016\/j.aohep.2025.101935_bib0007","doi-asserted-by":"crossref","unstructured":"Heimbach J.K., Kulik L.M., Finn R.S., Sirlin C.B., Abecassis M.M., Roberts L.R., et al. AASLD Guidelines for the Treatment of Hepatocellular Carcinoma 2017. https:\/\/doi.org\/10.1002\/hep.29086\/suppinfo.","DOI":"10.1002\/hep.29086"},{"key":"10.1016\/j.aohep.2025.101935_bib0008","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1159\/000509424","article-title":"Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 Edition)","volume":"9","author":"Zhou","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.aohep.2025.101935_bib0009","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/TP.0000000000002361","article-title":"Should patients with NAFLD\/NASH be surveyed for HCC?","volume":"103","author":"Reig","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.aohep.2025.101935_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20294","article-title":"Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014\u20132019","volume":"3","author":"Wong","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.aohep.2025.101935_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100876","article-title":"Changing epidemiology of hepatocellular carcinoma in South America: a report from the South American liver research network","volume":"28","author":"Farah","year":"2023","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2025.101935_bib0012","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-0039-3399561","article-title":"Epidemiology of liver cancer in Latin America: current and future trends","volume":"40","author":"Carrilho","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.aohep.2025.101935_bib0013","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jhep.2023.02.022","article-title":"International liver cancer association (ILCA) white paper on hepatocellular carcinoma risk stratification and surveillance","volume":"79","author":"Singal","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.101935_bib0014","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/hep.32434","article-title":"Risk factors for HCC in contemporary cohorts of patients with cirrhosis","volume":"77","author":"Kanwal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2025.101935_bib0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.aohep.2020.06.003","article-title":"Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma","volume":"19","author":"Pi\u00f1ero","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2025.101935_bib0016","unstructured":"M\u00e9ndez-S\u00e1nchez N., Ridruejo E., Alves de Mattos A., Ch\u00e1vez-Tapia N.C., Zapata R., Paran\u00e1 R., et al. Asociaci\u00f3n Latinoamericana para el Estudio del H\u00edgado (ALEH) Gu\u00edas Cl\u00ednicas para el Manejo del Carcinoma Hepatocelular A nombre de la ALEH: s4-s40. vol. 13. 2014."},{"key":"10.1016\/j.aohep.2025.101935_bib0017","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.aohep.2025.101935_bib0018","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/lt.25744","article-title":"Direct-acting antivirals and hepatocellular carcinoma: no evidence of higher wait-list progression or posttransplant recurrence","volume":"26","author":"Pi\u00f1ero","year":"2020","journal-title":"Liver Transplant"},{"key":"10.1016\/j.aohep.2025.101935_bib0019","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2025.101935_bib0020","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s10620-018-5390-z","article-title":"Surveillance for hepatocellular carcinoma: does the place where ultrasound is performed impact its effectiveness?","volume":"64","author":"Pi\u00f1ero","year":"2019","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.aohep.2025.101935_bib0021","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.cgh.2021.06.012","article-title":"Dynamic changes in ultrasound quality for hepatocellular carcinoma screening in patients with cirrhosis","volume":"20","author":"Schoenberger","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2025.101935_bib0022","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2025.101935_bib0023","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.aohep.2020.06.003","article-title":"Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma","volume":"19","author":"Pi\u00f1ero","year":"2020","journal-title":"Ann Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2025.101935_bib0024","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000422","article-title":"Alpha-fetoprotein: past, present, and future","volume":"8","author":"Yeo","year":"2024","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.aohep.2025.101935_bib0025","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.101935_bib0026","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000506834","article-title":"A comparison of biannual two-phase low-dose liver CT and US for HCC surveillance in a group at high risk of HCC development","volume":"9","author":"Yoon","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.aohep.2025.101935_bib0027","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/hep.24545","article-title":"Ultrasonographic surveillance of hepatocellular carcinoma in cirrhosis: a randomized trial comparing 3- and 6-month periodicities","volume":"54","author":"Trinchet","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2025.101935_bib0028","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.101935_bib0029","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1572-0241.2006.00443.x","article-title":"Diagnostic and prognostic role of \u03b1-fetoprotein in hepatocellular carcinoma: both or neither?","volume":"101","author":"Farinati","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.aohep.2025.101935_bib0030","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0168-8278(00)00053-2","article-title":"Serum \u03b1-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status","volume":"34","author":"Trevisani","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.101935_bib0031","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.cgh.2022.01.047","article-title":"The performance of AFP, AFP-3, DCP as biomarkers for detection of hepatocellular carcinoma (HCC): a Phase 3 biomarker study in the United States","volume":"21","author":"Tayob","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2025.101935_bib0032","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/1055-9965.EPI-13-0870","article-title":"The detection of hepatocellular carcinoma using a prospectively developed and validated model based on serological biomarkers","volume":"23","author":"Johnson","year":"2014","journal-title":"Cancer Epidemiol Biomark Prevent"},{"key":"10.1016\/j.aohep.2025.101935_bib0033","doi-asserted-by":"crossref","first-page":"e0317","DOI":"10.1097\/HC9.0000000000000317","article-title":"Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies","volume":"7","author":"Piratvisuth","year":"2023","journal-title":"Hepatol Commun"},{"issue":"10","key":"10.1016\/j.aohep.2025.101935_bib0034","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000264","article-title":"Validation and optimization of AFP-based biomarker panels for early HCC detection in Latin America and Europe","volume":"7","author":"Beudeker","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2025.101935_bib0035","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1053\/j.gastro.2015.10.004","article-title":"The updated model: an adjusted serum alpha-fetoprotein-based algorithm for hepatocellular carcinoma detection with hepatitis C virus-related cirrhosis","volume":"149","author":"White","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2025.101935_bib0036","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1002\/hep4.2045","article-title":"Comparison of a multitarget blood test to ultrasound and alpha-fetoprotein for hepatocellular carcinoma surveillance: results of a network meta-analysis","volume":"6","author":"Singal","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.aohep.2025.101935_bib0037","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma","volume":"130","author":"Zhang","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.aohep.2025.101935_bib0038","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia\u2013Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.aohep.2025.101935_bib0039","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/lt.24793","article-title":"Developing multicenter consortia in liver disease in Latin America: challenges and opportunities","volume":"23","author":"Mendizabal","year":"2017","journal-title":"Liver Transplant"},{"key":"10.1016\/j.aohep.2025.101935_bib0040","doi-asserted-by":"crossref","unstructured":"Fassio E., D\u00edaz S., Santa C., Elisa Reig M., Mart\u00ednez Artola Y., Alves de Mattos A., et al. 6 3 Etiology of hepatocarcinoma in Latin America. vol. 9. 2010.","DOI":"10.1016\/S1665-2681(19)31681-3"},{"key":"10.1016\/j.aohep.2025.101935_bib0041","unstructured":"Paranagu\u00e1-Vezozzo D.C., Ono S.K., Alvarado-Mora M.V., Farias A.Q., Cunha-Silva M., D Fran\u00e7a J.I., et al. Epidemiology of HCC in Brazil: incidence and risk factors in a ten-year cohort. n.d."},{"key":"10.1016\/j.aohep.2025.101935_bib0042","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/MEG.0000000000000272","article-title":"Screening for liver cancer during transplant waiting list: a multicenter study from South America","volume":"27","author":"Pi\u00f1ero","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2025.101935_bib0043","doi-asserted-by":"crossref","first-page":"10219","DOI":"10.3748\/wjg.v22.i46.10219","article-title":"Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: a 10-year retrospective cohort study","volume":"22","author":"Appel-Da-Silva","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2025.101935_bib0044","doi-asserted-by":"crossref","first-page":"454","DOI":"10.6061\/clinics\/2017(08)01","article-title":"Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage","volume":"72","author":"Kikuchi","year":"2017","journal-title":"Clinics"},{"key":"10.1016\/j.aohep.2025.101935_bib0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/liv.13502","article-title":"Hepatocellular carcinoma in South America: evaluation of risk factors, demographics and therapy","volume":"38","author":"Debes","year":"2018","journal-title":"Liver Int"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125001607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125001607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T09:31:05Z","timestamp":1764667865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125001607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1665268125001607"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.101935","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cHepatocellular carcinoma surveillance: Current challenges in Latin America\u201d","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.101935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101935"}}